Results of the Multivariate Analysis for the 5-Year Overall Survival
| . | Group I (n = 55) . | Group II (n = 45) . | ||||
|---|---|---|---|---|---|---|
| Relative Risk . | 95% CI . | P Value . | Relative Risk . | 95% CI . | P Value . | |
| Hemoglobin level at transplant (>100 g/L = 0, ≤100 g/L = 1) | 8.3 | 1.9-35.3 | .004 | 11.3 | 1.5-84.8 | .02 |
| Grade III marrow fibrosis (osteomyelosclerosis) (no = 0, yes = 1) | 2.0 | 0.9-4.5 | .10 | 2.9 | 1.0-8.2 | .04 |
| . | Group I (n = 55) . | Group II (n = 45) . | ||||
|---|---|---|---|---|---|---|
| Relative Risk . | 95% CI . | P Value . | Relative Risk . | 95% CI . | P Value . | |
| Hemoglobin level at transplant (>100 g/L = 0, ≤100 g/L = 1) | 8.3 | 1.9-35.3 | .004 | 11.3 | 1.5-84.8 | .02 |
| Grade III marrow fibrosis (osteomyelosclerosis) (no = 0, yes = 1) | 2.0 | 0.9-4.5 | .10 | 2.9 | 1.0-8.2 | .04 |
Group I, overall group of patients. Group II, patients receiving an unmanipulated HLA matched-related transplant.
Abbreviation: CI, confidence interval.